BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36787273)

  • 1. Longitudinal study of wound healing status and bacterial colonisation of Staphylococcus aureus and Corynebacterium diphtheriae in epidermolysis bullosa patients.
    Fuentes I; Yubero MJ; Morandé P; Varela C; Oróstica K; Acevedo F; Rebolledo-Jaramillo B; Arancibia E; Porte L; Palisson F
    Int Wound J; 2023 Mar; 20(3):774-783. PubMed ID: 36787273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of wound microbes in epidermolysis bullosa: Results from the epidermolysis bullosa clinical characterization and outcomes database.
    Levin LE; Shayegan LH; Lucky AW; Hook KP; Bruckner AL; Feinstein JA; Whittier S; Lauren CT; Pope E; Lara-Corrales I; Wiss K; McCuaig CC; Powell J; Eichenfield LF; Levy ML; Diaz L; Glick SA; Paller AS; Price HN; Browning JC; Morel KD
    Pediatr Dermatol; 2021 Jan; 38(1):119-124. PubMed ID: 33247481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host-pathogen interactions in epidermolysis bullosa patients colonized with Staphylococcus aureus.
    van der Kooi-Pol MM; Duipmans JC; Jonkman MF; van Dijl JM
    Int J Med Microbiol; 2014 Mar; 304(2):195-203. PubMed ID: 24444717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominance of Staphylococcus Correlates with Wound Burden and Disease Activity in Dystrophic Epidermolysis Bullosa: A Prospective Case-Control Study.
    Reimer-Taschenbrecker A; Künstner A; Hirose M; Hübner S; Gewert S; Ibrahim S; Busch H; Has C
    J Invest Dermatol; 2022 Aug; 142(8):2117-2127.e8. PubMed ID: 35149000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common wound colonizers in patients with epidermolysis bullosa.
    Brandling-Bennett HA; Morel KD
    Pediatr Dermatol; 2010; 27(1):25-8. PubMed ID: 20199405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oleogel-S10 in Dystrophic Epidermolysis Bullosa: A Case Series Evaluating the Impact on Wound Burden Over Two Years.
    Torres Pradilla M; Álvarez E; Novoa M; Lozano I; Trujillo M
    Adv Ther; 2024 Feb; 41(2):867-877. PubMed ID: 38170434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wound culture isolated antibiograms and caregiver-reported skin care practices in children with epidermolysis bullosa.
    Singer HM; Levin LE; Garzon MC; Lauren CT; Planet PJ; Kittler NW; Whittier S; Morel KD
    Pediatr Dermatol; 2018 Jan; 35(1):92-96. PubMed ID: 29105824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eye Involvement and Management in Inherited Epidermolysis Bullosa.
    Bachir Y; Daruich A; Marie C; Robert MP; Bremond-Gignac D
    Drugs; 2022 Aug; 82(12):1277-1285. PubMed ID: 36074321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological mechanisms underlying progression of chronic wounds in recessive dystrophic epidermolysis bullosa.
    Huitema L; Phillips T; Alexeev V; Igoucheva O
    Exp Dermatol; 2021 Dec; 30(12):1724-1733. PubMed ID: 34142388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The eye in epidermolysis bullosa.
    Tong L; Hodgkins PR; Denyer J; Brosnahan D; Harper J; Russell-Eggitt I; Taylor DS; Atherton D
    Br J Ophthalmol; 1999 Mar; 83(3):323-6. PubMed ID: 10365041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrochemotherapy, a local treatment for squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.
    Bartolo J; Farricha V; Carvalhal S; Moura C; Abecasis N
    Dermatol Ther; 2020 Nov; 33(6):e14093. PubMed ID: 32720460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bloodstream Infection in Children With Epidermolysis Bullosa.
    García-Espinosa L; Del Rosal T; Quintana L; Maseda R; Grasa C; Falces-Romero I; Menéndez-Suso JJ; Pérez-Conde I; Méndez-Echevarría A; Aracil Santos FJ; Alonso LA; de Lucas R; Calvo C; Baquero-Artigao F
    Pediatr Infect Dis J; 2023 Jun; 42(6):510-514. PubMed ID: 36795569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gross motor development in children with epidermolysis bullosa.
    Gorrie A; Saad R; Garside L; Bailie C; Wargon O
    Child Care Health Dev; 2024 Jan; 50(1):e13194. PubMed ID: 38108617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa.
    Venugopal SS; Yan W; Frew JW; Cohn HI; Rhodes LM; Tran K; Melbourne W; Nelson JA; Sturm M; Fogarty J; Marinkovich MP; Igawa S; Ishida-Yamamoto A; Murrell DF
    J Am Acad Dermatol; 2013 Dec; 69(6):898-908.e7. PubMed ID: 24075228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective short-term study to evaluate methodologies for the assessment of disease extent, impact, and wound evolution in patients with dystrophic epidermolysis bullosa.
    Paller AS; Pope E; Rudin D; Malyala A; Ramsdell D; Johnson R; Landy H; Murrell DF;
    Orphanet J Rare Dis; 2022 Aug; 17(1):314. PubMed ID: 35964087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa.
    So JY; Nazaroff J; Iwummadu CV; Harris N; Gorell ES; Fulchand S; Bailey I; McCarthy D; Siprashvili Z; Marinkovich MP; Tang JY; Chiou AS
    Orphanet J Rare Dis; 2022 Oct; 17(1):377. PubMed ID: 36253825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purified type I collagen wound matrix improves chronic wound healing in patients with recessive dystrophic epidermolysis bullosa.
    Gorell ES; Leung TH; Khuu P; Lane AT
    Pediatr Dermatol; 2015; 32(2):220-5. PubMed ID: 25557742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell activation and bacterial infection in skin wounds of recessive dystrophic epidermolysis bullosa patients.
    Alexeev V; Huitema L; Phillips T; Cepeda R; de Los Cobos D; Perez RIM; Salas-Garza M; Fajardo-Ramirez OR; Ringpfeil F; Uitto J; Salas-Alanis JC; Igoucheva O
    Exp Dermatol; 2022 Sep; 31(9):1431-1442. PubMed ID: 35620886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional survey.
    Eng VA; Solis DC; Gorell ES; Choi S; Nazaroff J; Li S; de Souza MP; Murrell DF; Marinkovich MP; Tang JY
    J Am Acad Dermatol; 2021 Nov; 85(5):1161-1167. PubMed ID: 32199895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High genetic diversity of Staphylococcus aureus strains colonizing patients with epidermolysis bullosa.
    van der Kooi-Pol MM; Veenstra-Kyuchukova YK; Duipmans JC; Pluister GN; Schouls LM; de Neeling AJ; Grundmann H; Jonkman MF; van Dijl JM
    Exp Dermatol; 2012 Jun; 21(6):463-6. PubMed ID: 22621190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.